Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 01:53PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.63 Insider Own30.55% Shs Outstand72.41M Perf Week3.59%
Market Cap334.53M Forward P/E- EPS next Y-1.40 Insider Trans0.00% Shs Float50.29M Perf Month14.64%
Income-91.33M PEG- EPS next Q-0.35 Inst Own47.22% Short Float / Ratio0.18% / 0.51 Perf Quarter45.28%
Sales2.21M P/S151.37 EPS this Y27.42% Inst Trans-3.23% Short Interest0.09M Perf Half Y6.94%
Book/sh2.73 P/B1.70 EPS next Y3.85% ROA-37.14% Target Price12.30 Perf Year116.39%
Cash/sh2.65 P/C1.74 EPS next 5Y- ROE-49.16% 52W Range2.06 - 5.63 Perf YTD46.67%
Dividend- P/FCF- EPS past 5Y-118.51% ROI-38.88% 52W High-17.94% Beta-1.24
Dividend %- Quick Ratio11.63 Sales past 5Y0.29% Gross Margin- 52W Low124.40% ATR0.43
Employees102 Current Ratio11.63 Sales Q/Q1108.43% Oper. Margin-4319.47% RSI (14)57.62 Volatility11.80% 10.50%
OptionableYes Debt/Eq0.28 EPS Q/Q54.56% Profit Margin-4136.55% Rel Volume0.44 Prev Close4.70
ShortableYes LT Debt/Eq0.25 EarningsNov 07 BMO Payout- Avg Volume182.15K Price4.62
Recom1.08 SMA205.22% SMA5021.53% SMA20017.65% Volume54,960 Change-1.70%
Date Action Analyst Rating Change Price Target Change
Sep-29-23Initiated Oppenheimer Outperform $13
Jun-23-23Initiated Raymond James Outperform $13
Dec-01-22Resumed B. Riley Securities Buy $10
Nov-30-22Initiated SVB Leerink Outperform $6
Sep-16-22Initiated Truist Buy $10
Jul-06-22Initiated William Blair Outperform
Oct-19-21Resumed Morgan Stanley Overweight $19
Aug-26-21Initiated B. Riley Securities Buy $17
Jul-21-20Initiated Wedbush Outperform $25
Jul-21-20Initiated Jefferies Buy $25
Nov-27-23 09:55AM
Nov-16-23 06:45AM
Nov-08-23 04:15PM
08:28AM Loading…
Nov-07-23 08:28AM
Oct-16-23 07:50AM
Oct-12-23 07:45AM
Sep-06-23 04:25PM
Sep-05-23 04:10PM
Aug-14-23 07:55AM
Aug-09-23 04:05PM
Aug-08-23 08:15AM
07:00AM Loading…
Aug-05-23 03:30PM
Jul-06-23 04:05PM
Jun-29-23 10:08AM
Jun-26-23 08:05AM
Jun-16-23 08:05AM
Jun-07-23 07:35AM
May-31-23 04:10PM
May-12-23 06:09AM
May-11-23 07:15AM
May-10-23 08:34AM
May-09-23 07:45AM
May-02-23 04:00PM
Apr-20-23 04:15PM
04:25PM Loading…
Apr-19-23 04:25PM
Apr-13-23 09:47AM
Apr-12-23 04:05PM
Apr-05-23 04:10PM
Mar-20-23 04:05PM
Mar-16-23 08:45AM
Mar-08-23 04:35PM
Mar-02-23 04:35PM
Feb-14-23 07:59AM
Feb-13-23 04:05PM
Feb-07-23 04:10PM
Jan-20-23 08:33AM
Jan-06-23 07:45AM
Jan-05-23 05:00PM
Jan-04-23 04:35PM
Dec-22-22 09:52AM
Dec-07-22 04:15PM
Nov-09-22 07:10AM
Nov-08-22 08:25AM
Nov-07-22 04:25PM
Oct-28-22 07:11AM
Oct-13-22 12:00PM
Oct-05-22 04:05PM
Oct-04-22 01:15PM
Sep-27-22 11:11AM
Sep-13-22 04:45PM
Sep-08-22 10:42AM
Sep-07-22 08:30AM
Aug-29-22 08:45AM
Aug-13-22 08:09AM
Aug-12-22 09:35AM
Aug-09-22 08:25AM
Aug-03-22 10:00AM
Aug-02-22 04:45PM
Jul-29-22 06:24AM
Jul-07-22 07:55AM
Jun-30-22 09:02AM
Jun-23-22 07:45AM
Jun-14-22 04:25PM
Jun-10-22 07:42AM
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.